Cargando…

CD133 Expression in Normal Skin and in Epithelial Cutaneous Tumors

Background. Expression of human CD133 (human prominin-1) in cancer cells has been postulated to be a marker of stemness and is considered as a putative marker of cancer stem cells (CSCs). We designed a study to describe the expression pattern of CD133 in normal skin and in epithelial cutaneous neopl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nam-Cha, S. H., Serrano-Vargas, R., Escario, E., Azaña, J. M., Calero-Oliver, R., Martín, A. G., Poblet, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786506/ https://www.ncbi.nlm.nih.gov/pubmed/24102054 http://dx.doi.org/10.1155/2013/385604

Ejemplares similares

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

CD133 in brain tumor: the prognostic factor
por: Li, Bin, et al.
Publicado: (2016)

THE CD133-POSITIVE COLON CANCER CELL PHENOTYPE IS MORE INTERACTIVE WITH THE TUMOR MICROENVIRONMENT COMPARED TO CD133-NEGATIVE CELL
por: Chao, Celia, et al.
Publicado: (2011)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Clonal dominance of CD133(+) subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma
por: SHARMA, BHUVNESH K., et al.
Publicado: (2012)

CD133/Src Axis Mediates Tumor Initiating Property and Epithelial-Mesenchymal Transition of Head and Neck Cancer
por: Chen, Yu-Syuan, et al.
Publicado: (2011)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53
por: Park, E K, et al.
Publicado: (2015)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer
por: Pellacani, Davide, et al.
Publicado: (2011)

CD133 Is a Marker of Bioenergetic Stress in Human Glioma
por: Griguer, Corinne E., et al.
Publicado: (2008)

Non-Invasive In Vivo Imaging of Tumor-Associated CD133/Prominin
por: Tsurumi, Chizuko, et al.
Publicado: (2010)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma()()
por: Stafman, Laura L., et al.
Publicado: (2018)

Evaluation of CD133 and CD56/NCAM expression in Wilms tumor and their association with prognostic factors
por: Jafarian, Amir Hossein, et al.
Publicado: (2020)

Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium
por: Al-Kaabi, Methaq, et al.
Publicado: (2022)

Normal Skin Cells Increase Aggressiveness of Cutaneous Melanoma by Promoting Epithelial-to-Mesenchymal Transition via Nodal and Wnt Activity
por: Untiveros, Gustavo, et al.
Publicado: (2021)

Prognostic impact of CD133 expression in Endometrial Cancer Patients
por: Mancebo, G., et al.
Publicado: (2017)

Identification of CD133-Positive Radioresistant Cells in Atypical Teratoid/ Rhabdoid Tumor
por: Chiou, Shih-Hwa, et al.
Publicado: (2008)

CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis
por: LU, CANRONG, et al.
Publicado: (2013)

CD133 Expression in the Nucleus Is Associated with Endometrial Carcinoma Staging and Tumor Angioinvasion
por: Pietrus, Milosz, et al.
Publicado: (2021)

CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis
por: Ding, Qiang, et al.
Publicado: (2014)

IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer
por: Lee, Soo Ok, et al.
Publicado: (2015)

CD133(+) brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence
por: Garg, N, et al.
Publicado: (2017)

CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009)

CD133, Selectively Targeting the Root of Cancer
por: Schmohl, Jörg U., et al.
Publicado: (2016)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

基因芯片筛选CD133(+)/CD133(-)肺腺癌细胞中新的耐药基因
Publicado: (2014)

DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies
por: Cervantes-Madrid, Diana, et al.
Publicado: (2017)

CD133/Prom1 marks proximal mouse oviduct epithelial progenitors and adult epithelial cells with a low generative capacity
por: Ford, Matthew J., et al.
Publicado: (2023)

Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021)

CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer
por: Sato-Dahlman, Mizuho, et al.
Publicado: (2017)

Clinical significance of CD133 and Nestin in astrocytic tumor: The correlation with pathological grade and survival
por: Zhang, Qingping, et al.
Publicado: (2019)

Investigating the Link between Molecular Subtypes of Glioblastoma, Epithelial-Mesenchymal Transition, and CD133 Cell Surface Protein
por: Zarkoob, Hadi, et al.
Publicado: (2013)

Epithelial-mesenchymal transition and metastatic ability of CD133(+) colorectal cancer stem-like cells under hypoxia
por: Okada, Masamichi, et al.
Publicado: (2021)

CD133 expression in chemo-resistant Ewing sarcoma cells
por: Jiang, Xiaohua, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_28kb7vc7doce2tpcnp6ujqrjp8